Tal Burt

3.0k total citations
48 papers, 2.1k citations indexed

About

Tal Burt is a scholar working on Pharmacology, Pharmacology and Psychiatry and Mental health. According to data from OpenAlex, Tal Burt has authored 48 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pharmacology, 11 papers in Pharmacology and 9 papers in Psychiatry and Mental health. Recurrent topics in Tal Burt's work include Pharmacogenetics and Drug Metabolism (11 papers), Treatment of Major Depression (10 papers) and Health Systems, Economic Evaluations, Quality of Life (6 papers). Tal Burt is often cited by papers focused on Pharmacogenetics and Drug Metabolism (11 papers), Treatment of Major Depression (10 papers) and Health Systems, Economic Evaluations, Quality of Life (6 papers). Tal Burt collaborates with scholars based in United States, United Kingdom and Japan. Tal Burt's co-authors include Harold A. Sackeïm, Sarah H. Lisanby, A. John Rush, Mustafa M. Husain, Lauren B. Marangell, Mark S. George, Kousik Krishnan, Ziad Nahas, Naresh P. Emmanuel and Graham Lappin and has published in prestigious journals such as PLoS ONE, Nature Reviews Drug Discovery and Biological Psychiatry.

In The Last Decade

Tal Burt

48 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tal Burt United States 24 671 600 517 509 261 48 2.1k
Charles R. Conway United States 25 929 1.4× 586 1.0× 818 1.6× 530 1.0× 511 2.0× 66 2.4k
Markus Kosel Switzerland 22 581 0.9× 418 0.7× 458 0.9× 622 1.2× 563 2.2× 58 2.3k
Nathan Herrmann Canada 25 344 0.5× 779 1.3× 592 1.1× 352 0.7× 252 1.0× 62 3.2k
Chih‐Sung Liang Taiwan 28 501 0.7× 1.0k 1.7× 234 0.5× 423 0.8× 248 1.0× 236 2.8k
Ann M. Callahan United States 17 655 1.0× 814 1.4× 209 0.4× 579 1.1× 161 0.6× 39 2.0k
Nunzio Pomara United States 30 412 0.6× 1.1k 1.8× 559 1.1× 697 1.4× 205 0.8× 131 3.5k
Michael Obermeier Germany 27 343 0.5× 1.4k 2.3× 544 1.1× 355 0.7× 120 0.5× 65 2.5k
Edmond Teng United States 27 338 0.5× 1.2k 1.9× 296 0.6× 426 0.8× 254 1.0× 80 2.6k
Ole Köhler‐Forsberg Denmark 26 389 0.6× 899 1.5× 436 0.8× 144 0.3× 134 0.5× 92 3.6k
Andreas Conca Italy 27 447 0.7× 990 1.6× 440 0.9× 295 0.6× 143 0.5× 137 2.2k

Countries citing papers authored by Tal Burt

Since Specialization
Citations

This map shows the geographic impact of Tal Burt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tal Burt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tal Burt more than expected).

Fields of papers citing papers by Tal Burt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tal Burt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tal Burt. The network helps show where Tal Burt may publish in the future.

Co-authorship network of co-authors of Tal Burt

This figure shows the co-authorship network connecting the top 25 collaborators of Tal Burt. A scholar is included among the top collaborators of Tal Burt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tal Burt. Tal Burt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Choi, Yun Jung, Soyoung Yoo, Seong Yoon Kim, et al.. (2016). Knowledge and Perception about Clinical Research Shapes Behavior: Face to Face Survey in Korean General Public. Journal of Korean Medical Science. 31(5). 674–674. 16 indexed citations
3.
Fam, Johnson, A. John Rush, Tal Burt, et al.. (2015). Thyroid Autoimmune Antibodies and Major Depressive Disorder in Women. Annals of the Academy of Medicine Singapore. 44(8). 284–289. 13 indexed citations
4.
Gupta, Saurabh, Kenneth Gersing, Alaattin Erkanli, & Tal Burt. (2015). Antidepressant Regulatory Warnings, Prescription Patterns, Suicidality and Other Aggressive Behaviors in Major Depressive Disorder and Anxiety Disorders. Psychiatric Quarterly. 87(2). 329–342. 10 indexed citations
5.
Burt, Tal, Douglas Rouse, Kihak Lee, et al.. (2015). Intraarterial Microdosing: A Novel Drug Development Approach, Proof-of-Concept PET Study in Rats. Journal of Nuclear Medicine. 56(11). 1793–1799. 10 indexed citations
6.
Lappin, Graham, Robert J. Noveck, & Tal Burt. (2013). Microdosing and drug development: past, present and future. Expert Opinion on Drug Metabolism & Toxicology. 9(7). 817–834. 67 indexed citations
7.
Sackeïm, Harold A., Steven P. Roose, & Tal Burt. (2005). Optimal Length of Antidepressant Trials in Late-Life Depression. Journal of Clinical Psychopharmacology. 25(4). S34–S37. 26 indexed citations
8.
Dahl, Andreas, Arun Ravindran, Christer Allgulander, et al.. (2005). Sertraline in generalized anxiety disorder: efficacy in treating the psychic and somatic anxiety factors. Acta Psychiatrica Scandinavica. 111(6). 429–435. 26 indexed citations
9.
Kamijima, Kunitoshi, et al.. (2005). A placebo-controlled, randomized withdrawal study of sertraline for panic disorder in Japan. International Clinical Psychopharmacology. 20(5). 265–273. 19 indexed citations
10.
Kamijima, Kunitoshi, et al.. (2005). A placebo-controlled, randomized withdrawal study of sertraline for major depressive disorder in Japan. International Clinical Psychopharmacology. 21(1). 1–9. 29 indexed citations
11.
Steiner, Meir, et al.. (2004). Gender differences in clinical presentation and response to sertraline treatment of generalized anxiety disorder. Human Psychopharmacology Clinical and Experimental. 20(1). 3–13. 40 indexed citations
12.
Finkel, Sanford I., Jacobo Mintzer, Maurice W. Dysken, et al.. (2004). A randomized, placebo‐controlled study of the efficacy and safety of sertraline in the treatment of the behavioral manifestations of Alzheimer's disease in outpatients treated with donepezil. International Journal of Geriatric Psychiatry. 19(1). 9–18. 116 indexed citations
13.
Doraiswamy, P. Murali, Kousik Krishnan, Thomas E. Oxman, et al.. (2003). Does Antidepressant Therapy Improve Cognition in Elderly Depressed Patients?. The Journals of Gerontology Series A. 58(12). M1137–M1144. 100 indexed citations
14.
Sheikh, Javaid I., Erin L. Cassidy, P. Murali Doraiswamy, et al.. (2003). Efficacy, Safety, and Tolerability of Sertraline in Patients with Late‐Life Depression and Comorbid Medical Illness. Journal of the American Geriatrics Society. 52(1). 86–92. 67 indexed citations
15.
Devanand, Davangere P., Jocelyn Y. Cheng, Tal Burt, et al.. (2002). Late onset dysthymic disorder and major depression differ from early onset dysthymic disorder and major depression in elderly outpatients. Journal of Affective Disorders. 78(3). 259–267. 41 indexed citations
16.
Burt, Tal, et al.. (2000). Learning and memory in bipolar and unipolar major depression: effects of aging.. PubMed. 13(4). 246–53. 36 indexed citations
17.
Burt, Tal. (2000). Donepezil and related cholinesterase inhibitors as mood and behavioral controlling agents. Current Psychiatry Reports. 2(6). 473–478. 30 indexed citations
18.
George, Mark S., Harold A. Sackeïm, A. John Rush, et al.. (2000). Vagus nerve stimulation: a new tool for brain research and therapy∗. Biological Psychiatry. 47(4). 287–295. 325 indexed citations
19.
Burt, Tal, et al.. (1999). Donepezil in treatment-resistant bipolar disorder. Biological Psychiatry. 45(8). 959–964. 59 indexed citations
20.
IsHak, Waguih William & Tal Burt. (1998). Computer Applications in Psychiatry: Role in Patient Care, Education, Research and Communication. CyberPsychology & Behavior. 1(2). 147–150. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026